Please login to the form below

Not currently logged in
Email:
Password:

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

Jackie FouseCancer and rare genetic disease focused group Agios Pharmaceuticals has appointed Jackie Fouse to its board of directors as the company prepares to launch its first precision medicine.

She said: “The execution across Agios’ research and clinical development programmes is remarkable, and I'm pleased to be joining the board during this exciting time.

“I look forward to working with the Agios team.”

Fouse’s career saw her join Celgene in 2010 as its chief financial officer and she most recently served as its president and chief operating officer until earlier this year.

Prior to her tenure at Celgene, Fouse worked for Alcon Laboratories, an ophthalmic pharmaceutical and medical device company.

David Schenkein, chief executive officer at Agios, said: “Through her tenure at Celgene we had the privilege of working with Jackie and seeing first hand the value she brings to a growing biotechnology company, so we are thrilled to welcome her to the Agios board of directors.”

14th December 2017

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics